Location: Home
  • search
  • go
  • Relate News
  • 6/17/2022CDE Solicits Comments on the Draft Technical Guidelines for Design and...
  • 6/17/2022CDE Notice on Initiating Member Screening of Clinical Expert Advisory ...
  • 6/3/2022NMPA Speeds Up Approval of Pediatric Drugs
  • 5/10/2022NMPA Solicits Comments on the Draft Implementation Rules for Drug Admi...
  • 4/29/2022CDE Seeks Participation for Questionnaire Survey on Pediatric Drug R&D...
  • 4/29/2022BMS and Chinese Partner LianBio Won FDA Nod for Camzyos to Treat Hea...
  • 4/27/2022Significant Increase in Diabetes Prevalence Observed in China
  • 4/21/2022CDE Solicits Comments on Two Draft Documents on Pediatric Drug Informa...
  • 4/11/2022India Hopes 'Pharma City' Will Break China's Grip on Industry
  • 12/20/2021Novartis and BeiGene Expands Collaboration to BeiGene's TIGIT Inhibito...
  • 12/1/2021NMPA Issues Technical Guidelines Related to Companion Diagnostic Reag...
  • 12/1/2021Genetron and AstraZeneca China Enter Co-Development Agreement for MR...
  • 11/30/2021JPO Releases Final Tender Outcome of the 6th VBP
  • 10/15/2021Gan & Lee Concludes Phase 3 Studies of Biosimilar Insulin Glargine (G...
  • 10/15/2021Adocia's Partner Tonghua Dongbao Cleared to Start Ultra-Rapid Insulin ...
  • 10/14/2021Dr. Reddy's Becomes the First Indian Company to Launch An Anticancer i...
  • 10/11/2021Impact of the 2020 China Diabetes Society Guideline on the Prevalence ...
  • 9/15/2021Hua Medicine and Sinopharm Enter Supply Chain Strategic Cooperation
  • 9/14/2021CDE Issues the Technical Guidelines for Clinical Trial of Improvement ...
  • 9/7/2021NMPA Announces Package Insert Revision of Diammonium Glycyrrhizinate F...
  • 8/23/2021BioDuro-Sundia Acquires US-based Phase III/Commercial Drug Product Man...
  • 8/20/2021Novartis Receives Approval for Lucentis and Launches Galvus in China
  • 8/3/2021India Initiates Anti-dumping Probe against Chemical from China for Ato...
  • 6/25/2021Innovent Releases Results of a Phase 1 Clinical Study of IBI362 in Ove...
  • 4/23/2021Hua Medicine Files Chinese NDA for Dorzagliatin
  • 4/14/2021BioDuro-Sundia Initiates GMP Clinical Batch Manufacturing at New China...
  • 2/23/2021Indian Pharma Firms Go Local Seeking to End Reliance on China
  • 12/28/2020Chinese Hypertension Prevalence Up 27.5% in the Past Five Years
  • 12/24/2020Obesity Continues to Surge in China Due to Unhealthy Lifestyles
  • 12/10/2020China vs. India: the Fight for Pharma Supremacy
  • Page:3/16 Total number of articles:474: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group